Additional European Equity News

DSM-Firmenich (DSFIR NA) - Q1 2026 (EUR): Sales 2.28bln (exp. 2.24bln), Adj. EBITDA 434mln (exp. 434.9mln).  4% LFL sales growth, with strong performance in Perfumery & Beauty. €500 million share buyback for capital reduction, launched March 12, 2026. FY 2026 outlook maintained. (DSM-Firmenich) 

Diageo (DGE LN)  - Q3 2026 (USD): Neet Sales 4.47bln (prev. 4.37bln Y/Y). Strong organic net sales growth was delivered in Europe, LAC and Africa with some benefit from Easter timing and advance sales ahead of the upcoming FIFA World Cup. In North America, organic net sales declined high-single-digit reflecting continued US Spirits weakness. Fiscal 26 guidance unchanged. (Diageo) 

Smith & Nephew (SN/ LN) - Q1 2026 (USD): Revenue 1.5bln, +3.1% Y/Y (exp. +3.7%); co. to buyback USD 500mln in shares. Affirms FY26 guidance. (Smith & Nephew)